Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VVOS compared with NXXT: revenue, margins and what each company keeps, and the suppliers and customers both name
VVOS
Vivos Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
NXXT
Nextnrg, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VVOS
Vivos Therapeutics, Inc.
vs
NXXT
Nextnrg, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: VVOS, NXXT.
Role chip = supplier or customer
Source: SEC EDGAR
VVOS
Vivos Therapeutics, Inc.
Change
0.11
▲
+1.48%
· post 0.12
Mkt cap
$2.2M
Revenue
$5M
Q2 FY26
Revenue
$17M
FY25
NXXT
Nextnrg, Inc.
Change
2.54
▲
+13.37%
· post 2.50
Closed
Nov 3 '26
Mkt cap
$4.6M
Revenue
$28M
Q2 FY26
Revenue
—
vs
Compare
Closed
Nov 3 '26
VVOS
Vivos Therapeutics, Inc.
vs
NXXT
Nextnrg, Inc.
0.11
▲
+1.48%
post 0.12
Price
2.54
▲
+13.37%
post 2.50
$2.2M
Mkt cap
$4.6M
Q2 FY26
$5M
Revenue
$28M
Q2 FY26
FY25
$17M
Revenue
—
Change
Change
VVOS
0.11
▲
+1.48%
vs
NXXT
2.54
▲
+13.37%
Closed
Nov 3 '26